期刊文献+

肾癌组织中Mina53和CapG表达及临床意义 被引量:2

Expressions and significance of Mina53 and CapG in renal cell carcinoma
下载PDF
导出
摘要 目的探讨Mina53(Myc-induced nuclear antigen 53)和CapG(capping protein)在肾细胞癌中的表达及临床意义。方法利用免疫组化SP法测定66例经HE染色病理确诊肾细胞癌(RCC)组织和30例癌旁组织中Mina53和CapG的表达,并分析其与病理分级及临床分期之间的关系。结果与RCC旁组织比较,RCC中Mina53和CapG阳性表达明显升高。Mina53和CapG在RCC组织不同的病理分级中,G3和G2明显高于G1表达;在TNM分期中,Mina53和CapG在T3、T4中的表达明显高于T1、T2。Mina53和CapG的表达与远处转移和复发有一定关系,且两者表达呈显著相关性(P<0.05)。结论 Mina53和CapG在RCC组织中的表达与临床病理分级、TNM分期、复发和转移有关,这对临床治疗和预后判断有一定的参考意义。 Objective To study the expressions of MinaS3 ( Myc-induced nuclear antigen 53 ) and CapG ( capping protein) in renal cell carcinoma(RCC) and its role in carcinogenesis and tumor progression. Methods The expressions of MinaS3 and CapG were determined in RCC (n = 66) and normalrenal tissues (n = 30) by immunohistochemistry, and the relationship between the expressions of MinaS3 and CapG with clinicopathological characteristics were analyzed. Results Comparing with normal renal tissues,expressions of MinaS3 and CapG were significantly increased in RCC. Expressions of Mina53 and CapG for pathological grades G3 and G2 were significantly higher than the G1, the difference was statistically significant in RCC; and in TNM staging, MinaS3 and CapG in T3 ,T4 expression was significantly higher than T1 ,T2. Mina53 and CapG expression had a certain relationship between distance metastasis and recurrence and showed a significant correlation with the expressions ( P 〈 0.05). Conclusion MinaS3 and CapG expression in RCC tissues and clinical pathological stage, TNM grade, metastasis and recurrence were correlated ,which is the certain significance of clinical treatment and prognosis in RCC.
出处 《局解手术学杂志》 2012年第4期381-383,共3页 Journal of Regional Anatomy and Operative Surgery
关键词 肾细胞癌 MINA53 CapG 基因表达 免疫组织化学 renal cell carcinoma Mina53 CapG gene expression immunohistoehemistry
  • 相关文献

参考文献7

二级参考文献82

  • 1苗芳,李劲松.EZH2和Ki-67在胃癌中的表达及其临床意义[J].泰山医学院学报,2008,29(2):87-89. 被引量:6
  • 2杜岳峰,邢毅飞,曾甫清,陆鹏,王美玉,刘先艮.Syndecan-1、MMP-1在肾癌中的表达及临床意义[J].山东医药,2006,46(21):29-30. 被引量:1
  • 3辛芝,战忠利.Wnt途径及其拮抗剂与肿瘤的关系[J].国际病理科学与临床杂志,2007,27(1):28-31. 被引量:2
  • 4Tsuneoka M, Koda Y, Soejima M, et al. A novel myc target gene, mina53, that is involved in cell proliferation.J Biol Chem, 2002, 277 (38): 35450-35459.
  • 5Teye K, Tsuneoka M, Arima N, et al. Increased expression of a Myc target gene Mina53 in human colon cancer. Am J Pathol, 2004, 164 (1): 205-216.
  • 6Tsuneoka M, Fujita H, Arima N, et al. Mina53 as a potential prognostic factor for esophageal squamous cell carcinoma. Clin Cancer Res, 2004, 10 (21): 7347-7356.
  • 7Zhang Q, Hu CM, Yuan YS, et al. Expression of Mina53 and its significance in gastric carcinoma. Int J Biol Markers, 2008, 23 (2): 83-88.
  • 8Kim JP, Kim YW, Yang HK, et al. Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J Surg, 1994, 18 (6): 872-878.
  • 9Fukahori S, Yano H, Tsuneoka M, et al. Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma. J Pediatr Surg, 2007, 42 (11): 1831-1840.
  • 10Ishizaki H, Yano H, Tsuneoka M, et al. Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma. Pathol Int, 2007, 57 (10): 672-680.

共引文献15

同被引文献21

  • 1吴云飞,徐惠绵,陈峻青.胃癌细胞增殖活性与淋巴结转移关系的研究[J].中华实验外科杂志,2004,21(5):527-529. 被引量:4
  • 2Xing J, Wang K, Liu PW, et al. MinaS3, a novel molecular marker for the diagnosis and prognosis of gastric adenocarcinoma[ J ]. Oncol Rep, 2014,31 (2) : 634-640.
  • 3Tan XP, Zhang Q, Dong WG, et al. Upregulated expression of MinaS3 in cholangiocarcinoma and its clinical significance [J]. Oncol Lett, 2012,3(5 ) : 1037-1041.
  • 4Yu M, Sun J, Thakur C, et al. Paradoxical roles of mineral dust induced gene on cell proliferation and migration/invasion[J]. PLoS One, 2014,9(2) :e87998.
  • 5Kuratomi K, Yano H, Tsuneoka M, et al. expression of Mina53 and Ki67 proteins in human primary gingival squamous cell carcinoma [ J ]. Kurume Med J, 2006,53 (3/4) : 71- 78.
  • 6Tsuneoka M, Fujita H, Arima N,et al. MinaS3 as a potential prognostic factor for esophageal squamous cell carcinoma [ J ]. Clin Cancer Res, 2004,10(21 ) :7347-7356.
  • 7Filiberti R, Parodi S, Libener R,et al. Diagnostic value of mesothelin in pleural fluids: comparison with CYFRA 21-1 and CEA[J]. Meal Oncol, 2013,30(2) :543.
  • 8Tang Y, Xu L.Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleura] effusion caused bypulmonary carcinoma [ J ]. J Exp Clin Cancer Res, 2013,32: 37.
  • 9Lv M, Mou Y, Wang P,et al. Diagnostic and predictive role of cell- free midkine in malignant pleural effusions [J]. J Cancer Res Clin Oncol, 2013,139(4) : 543-549.
  • 10王鹏,郭琳,王强.PTEN、Fas/FasL和MMP-2在胃癌组织的表达及其临床意义[J].中国普外基础与临床杂志,2009,16(12):991-995. 被引量:12

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部